- « Previous
- Clinical Pharmacology
- Next »
Claforan
Clinical Pharmacology
Claforan
NOTE: Many strains of the above organisms that are multiply resistant to other antibiotics, e.g. penicillins, cephalosporins, and aminoglycosides, are susceptible to cefotaxime sodium.
Cefotaxime sodium is active against some strains of Pseudomonas aeruginosa.
Anaerobes:
- Bacteroides species, including some strains of B. fragilis,
- Clostridium species (NOTE: Most strains of C. difficile are resistant.),
- Peptococcus species,
- Peptostreptococcus species, and
- Fusobacterium species (including F. nucleatum).
Cefotaxime sodium is highly stable in vitro to four of the five major classes of b-lactamases described by Richmond et al., including type IIIa (TEM) which is produced by many gram-negative bacteria. The drug is also stable to b-lactamase (penicillinase) produced by staphylococci. In addition, cefotaxime sodium shows high affinity for penicillin-binding proteins in the cell wall, including PBP: Ib and III.
Cefotaxime sodium also demonstrates in vitro activity against the following microorganisms but the clinical significance is unknown. Cefotaxime sodium exhibits in vitro minimal inhibitory concentrations (MICs) of 8 mcg/mL or less against most (>/=90%) strains of the following microorganisms; however, the safety and effectiveness of cefotaxime sodium in treating clinical infections due to these microorganisms have not been established in adequate and well-controlled clinical trials:
Aerobes, Gram-negative:
Providencia spp.
Salmonella spp. (including Salmonella typhi )
Shigella spp.
Cefotaxime sodium is highly stable in vitro to four of the five major classes of 5-lactamases described by Richmond et al. 1 , including type IIIa (TEM) which is produced by many gram-negative bacteria. The drug is also stable to (beta)-lactamase (penicillinase) produced by staphylococci. In addition, cefotaxime sodium shows high affinity for penicillin-binding proteins in the cell wall, including PBP: Ib and III.
Cefotaxime sodium and aminoglycosides have been shown to be synergistic in vitro against some strains of Pseudomonas aeruginosa but the clinical significance is unknown.
Susceptibility Tests
Dilution techniques:
Quantitative methods that are used to determine minimum inhibitory concentrations (MICs) provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure uses a standardized dilution method1 (broth or agar) or equivalent with cefotaxime sodium powder. The MIC values obtained should be interpreted according to the following criteria:
|
When testing organismsa other than Haemophilus spp., Neisseria gonorrhoeae, and Streptococcus spp. | ||
|
MIC (mcg/mL) |
Interpretation | |
|
<8 |
Susceptible (S) | |
|
16-32 |
Intermediate (I) | |
|
>64 |
Resistant (R) | |
| When testing Haemophilus spp.b | ||
|
Brand Name: Claforan
Generic Name: Cefotaxime
WebMD Resources
WebMD DailyGet breaking medical news. ENABLEX is a prescription medicine used in adults to treat the following symptoms due to a condition called overactive bladder:
IMPORTANT SAFETY INFORMATIONYou should not take once-daily ENABLEX if you have certain types of stomach problems, glaucoma, or have trouble emptying your bladder. Side effects of ENBLEX include blurred vision, and more commonly dry mouth, constipation, indigestion, and abdominal pain. Use caution when doing certain activities until you know how ENBALEX affects you. | ||

